Your browser doesn't support javascript.
loading
Prolonged infective SARS-CoV-2 omicron variant shedding in a patient with diffuse large B cell lymphoma successfully cleared after three courses of remdesivir.
Nakamura, Kiwamu; Sugiyama, Masahiro; Ishizuka, Hikari; Sasajima, Tomomi; Minakawa, Yoko; Sato, Hiroko; Miyazawa, Masatsugu; Kitakawa, Kazuhiro; Fujita, Shohei; Saito, Nozomi; Kashiwabara, Naoko; Kohata, Hironobu; Hara, Yasuka; Kanari, Yumiko; Shinka, Toshikatsu; Kanemitsu, Keiji.
Afiliación
  • Nakamura K; Department of Infection Control, Fukushima Medical University, Fukushima, Japan. Electronic address: kinakamu@fmu.ac.jp.
  • Sugiyama M; Infection Control Unit, Fukushima Rosai Hospital, Iwaki, Japan. Electronic address: sugiyama12@fukushimah.johas.go.jp.
  • Ishizuka H; Department of Oncology, Fukushima Rosai Hospital, Iwaki, Japan. Electronic address: fukurohikaish-cov19@yahoo.co.jp.
  • Sasajima T; Infection Control Unit, Fukushima Rosai Hospital, Iwaki, Japan. Electronic address: sasaji@fukushimah.johas.go.jp.
  • Minakawa Y; Infection Control Unit, Fukushima Rosai Hospital, Iwaki, Japan. Electronic address: kansen@fukushimah.johas.go.jp.
  • Sato H; Infection Control Unit, Fukushima Rosai Hospital, Iwaki, Japan. Electronic address: saikin@fukushimah.johas.go.jp.
  • Miyazawa M; Infection Control Unit, Fukushima Rosai Hospital, Iwaki, Japan. Electronic address: m-miyazawa@fukushimah.johas.go.jp.
  • Kitakawa K; Department of Microbiology, Fukushima Prefectural Institute of Public Health, Fukushima, Japan. Electronic address: kitakawa_kaduhiro_01@pref.fukushima.lg.jp.
  • Fujita S; Department of Microbiology, Fukushima Prefectural Institute of Public Health, Fukushima, Japan. Electronic address: fujita_syouhei_01@pref.fukushima.lg.jp.
  • Saito N; Department of Microbiology, Fukushima Prefectural Institute of Public Health, Fukushima, Japan. Electronic address: saitou_nozomi_01@pref.fukushima.lg.jp.
  • Kashiwabara N; Department of Microbiology, Fukushima Prefectural Institute of Public Health, Fukushima, Japan. Electronic address: kashiwabara_naoko_01@pref.fukushima.lg.jp.
  • Kohata H; Department of Microbiology, Fukushima Prefectural Institute of Public Health, Fukushima, Japan. Electronic address: kohata_hironobu_01@pref.fukushima.lg.jp.
  • Hara Y; Department of Infection Control, Fukushima Medical University, Fukushima, Japan. Electronic address: ya116211@fmu.ac.jp.
  • Kanari Y; Department of Social Health and Welfare, Fukushima Prefectural Government, Fukushima, Japan. Electronic address: kanari@fmu.ac.jp.
  • Shinka T; Iwaki City Public Health Institute, Iwaki, Japan. Electronic address: shinka-t@city.iwaki.lg.jp.
  • Kanemitsu K; Department of Infection Control, Fukushima Medical University, Fukushima, Japan. Electronic address: kane2@fmu.ac.jp.
J Infect Chemother ; 29(8): 820-824, 2023 Aug.
Article en En | MEDLINE | ID: mdl-37182841
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfoma de Células B Grandes Difuso / COVID-19 Límite: Aged / Humans / Male Idioma: En Revista: J Infect Chemother Asunto de la revista: MICROBIOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2023 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfoma de Células B Grandes Difuso / COVID-19 Límite: Aged / Humans / Male Idioma: En Revista: J Infect Chemother Asunto de la revista: MICROBIOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2023 Tipo del documento: Article